Kneerol OD Tablet SR

The sustained-release formulation ensures a steady plasma concentration, enhancing patient compliance by allowing once-daily dosing and minimizing peak-related adverse effects. Oxaceprol exerts its pharmacological action by inhibiting the synthesis of pro-inflammatory mediators, thereby reducing inflammation, pain, and swelling in affected tissues. Additionally, it has been shown to possess antioxidant properties, contributing to the protection of joint cartilage and promoting tissue repair.

Kneerol OD Tablet SR is generally well-tolerated, with a safety profile comparable to other NSAIDs, though caution is advised in patients with a history of gastrointestinal ulcers, renal impairment, or hypersensitivity to NSAIDs. It is recommended to be taken under medical supervision, with dosage adjustments based on clinical response and tolerability. This medication should be used as part of a comprehensive treatment plan including physical therapy and lifestyle modifications to optimize musculoskeletal health outcomes.